Navigation Links
Eigen Receives Two Grant Awards from U.S. Department of Health & Human Services
Date:4/22/2011

GRASS VALLEY, Calif., April 22, 2011 /PRNewswire/ -- Eigen is the proud recipient of two grant awards from the Qualifying Therapeutic Discovery Project (QTDP) funded by the U.S. Department of Health & Human Services. QTDP tax credits are provided under section 48D of the Internal Revenue Code (IRC), enacted as part of the Patient Protection and Affordable Care Act of 2010 (P.L. 111-148). Eigen received the maximum $244,000 award for each grant awarded in October, 2010, and January, 2011. These credits support biomedical research by small companies which may have major impact on the diagnosis and treatment of significant diseases.  

With this grant, Eigen continues to rapidly move forward, bringing breakthrough medical imaging products to market. Additionally, the QTDP grants have enabled the company to hire additional local talent to support growing company needs.  

Artemis, Eigen's flagship product, uses proprietary, next-generation imaging technology and provides solutions—not previously available—which enhance urologists' existing 2D ultrasound imagery with full color 3D modeling used for "smart" prostate biopsies.

"Artemis has provided a great leap forward in the diagnosis of prostate cancer," says Brian Burr, Eigen CEO. "It has added precision along with the ability to guide, track, and record exact biopsy locations. Artemis lets doctors re-biopsy the same location accurately in a subsequent biopsy. This has previously not been an option. Artemis technology provides high quality, real-time information that enhances how prostate cancer is managed. Better patient information equals better patient decisions."

Eigen is also breaking into the prostate cancer therapy market.  The company hopes to receive future support from such programs as the QTDP, allowing it to continue providing quality imaging devices to medical professionals worldwide.

About Eigen

Eigen is a
'/>"/>

SOURCE Eigen
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Morphotek Receives Grant to Support Development of Therapeutic Antibodies against Biowarfare Agents
2. MabVax Therapeutics Receives $1.8 Million in a Phase 2 Small Business Innovation Research Program Award From the National Cancer Institute
3. Morphotek®, Inc. Receives Beacon Award From CancerCare
4. Cellectis Receives Payment for License to Homologous Recombination Patents
5. China-Biotics Receives First U.S. Sales Order
6. BD Diagnostics Receives FDA Clearance for First Fully Automated Molecular Assays for HSV1 and HSV2 from Clinician-Collected External Anogenital Lesion Specimens
7. Teysuno™ (S-1) Receives European Marketing Authorization as First-Line Therapy for Advanced Gastric Cancer
8. ACT Receives Positive Opinion for Orphan Drug Designation from European Medicines Agency for hESC-Derived RPE Cells for Treatment of Stargardts Disease
9. Mylans Matrix Receives FDA Approval Under PEPFAR for Zidovudine Tablets, 100 mg
10. Everist Genomics Laboratory Receives Approval From U.S. Regulatory Authorities For High Complexity Clinical Testing
11. EMD Serono Receives Complete Response Letter From FDA on Cladribine Tablets New Drug Application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... Cellgen Diagnostics today launched ... a corporate lab for its genetic-based medical testing ... a critical component in the move from today’s ... of personalized medicine – a more predictive, preventive, ... contributions will support Cellgen’s intent to develop the ...
(Date:8/19/2014)... CA (PRWEB) August 19, 2014 Robin ... Parkinson’s disease can take on an individual. Symptoms ... decreased facial expression, problems swallowing and severe depression. ... the dying off of dopamine producing neurons of the ... from a disease that slowly and progressively gets worse, ...
(Date:8/19/2014)... Aug. 19, 2014 Research ... of the "Spectroscopy Equipment and Accessories ... to their offering. This ... Equipment and Accessories in US$ Thousands by ... spectrophotometers, Raman Spectrometers, NMR-EPR Spectrometers, Near Infrared ...
(Date:8/19/2014)... 19, 2014 In November 2012, the European ... Evaluation Report (PBRER) in a new PSUR – responding to ... benefit-risk profile of a drug. Adopted in many regions, the ... Present a comprehensive and critical analysis of new or ... Highlight any new evidence of the potential benefits of ...
Breaking Biology Technology:Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 2Cellgen Diagnostics Launches Indiegogo Crowdfunding Campaign for DNA Medical Testing Device 3As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 2As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 3Global Spectroscopy Equipment and Accessories - Strategic Business Report 2014 2Top Five Best Practices for Developing Your Periodic Benefit Risk Evaluation Report (PBRER), New Webinar Hosted by Xtalks 2
... VIENNA, Austria, November 28 f-star, an antibody,engineering company ... Modular Antibody Technology, today announced that it,has raised EUR ... of its Series,A financing round, originally co-led by Aescap ... raised in the Series A round,increases to EUR 9.0 ...
... 1-41 has significant ... and anti-amnesic benefits, GENEVA, Nov. 28 /PRNewswire-FirstCall/ - ... announce promising developments with,ANAVEX 1-41, the company,s lead drug ... 1-41 prevented oxidative stress,which damages and destroys cells and ...
... November 28 The results of a,study on ... desensitisation product, which is due to receive German ... VO52.06, which was carried out on 280,patients in ... the main evaluation criterion by,demonstrating a statistically significant ...
Cached Biology Technology:Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S 2Antibody Engineering Company f-star Raises EUR 3.0 Million in a Second Closing of its Series A Financing Round From Novo A/S 3Anavex advances drug candidate for treatment of Alzheimer's disease 2Anavex advances drug candidate for treatment of Alzheimer's disease 3Anavex advances drug candidate for treatment of Alzheimer's disease 4Anavex advances drug candidate for treatment of Alzheimer's disease 5STALLERGENES: ORALAIR Grasses: Positive Results of VO52.06 Paediatric Study 2
(Date:8/19/2014)... To improve students, chances of completing introductory ... of Houston (UH) implemented a comprehensive student success ... for failure. , Through a grant from ... Department of Biology and Biochemistry embarked on a ... Biology" for non-majors and "Introductory Biology" for science ...
(Date:8/19/2014)... It,s not a lemur. It,s not an African Bush Baby ... tiny, adorable and downright "cool" primate from Southeast Asia. , ... with," said Rafe Brown, curator-in-charge at the University of Kansas, ... extremely cute, furry body; a long tail with a furry ... tips that look a bit like the disks on the ...
(Date:8/19/2014)... a biomarker strongly associated with basal-like breast cancer, ... many types of chemotherapy. The biomarker, a protein ... therapeutics designed to treat this often deadly cancer. ... The Cancer Genome Atlas, molecular biologists Curt M. ... and bioinformatics techniques to detect patterns of gene ...
Breaking Biology News(10 mins):University of Houson program earns kudos for improving grades, retaining students 2University of Houson program earns kudos for improving grades, retaining students 3Philippine tarsier gets boost from Kansas research, and genetic proof of a new variety 2Philippine tarsier gets boost from Kansas research, and genetic proof of a new variety 3Biomarker in an aggressive breast cancer is identified 2Biomarker in an aggressive breast cancer is identified 3
... The decline of large predators and other "apex consumers" at ... the planet. The finding is reported by an international ... of the journal Science . The study looked ... and marine ecosystems and concluded "the loss of apex consumers ...
... 14, 2011 Two studies published in the current ... that consuming in-shell pistachios is a weight-wise approach to ... curb consumption and decrease calorie intake. ... pistachios ate 41-percent fewer calories compared to those who ...
... East Coast may be at risk to higher sea levels ... years, according to a new study by NOAA. The ... surges along the East Coast during the 2009-2010 El Nio ... NOAA,s Center for Operational Oceanographic Products and Services, examined water ...
Cached Biology News:Loss of large predators caused widespread disruption of ecosystems 2Loss of large predators caused widespread disruption of ecosystems 3In-shell pistachios: The original 'slow food?' 2In-shell pistachios: The original 'slow food?' 3Strong El Niño could bring increased sea levels, storm surges to US East Coast 2
... Universal Vacuum System UVS400 is a multi-tasking ... UVS400 combines a refrigerated vapor trap and ... single integrated unit. The easy-to-use, wide-mouth glass ... into single jar for easy disposal. The ...
... 2 products into 1:, , A multi-tube ... kit , ,The FastPrep System consists ... System Matrix and Isolation Kits. Samples are ... eliminating the use of metal probes and ...
... is a chromogenic substrate ... plasmids. In the presence ... lac + bacterial ... recombinant colonies appear white. ...
... The LCMS-2010EV is a fully flexible ... including conventional HPLC, high-speed HPLC, 1-D and ... prep scale separations. It incorporates a drying ... mist for high sensitivity, especially for low-to-medium ...
Biology Products: